The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus
Abstract
BACKGROUND: Although cIV-MDZ has emerged as a popular alternative to barbiturate therapy for refractory status epilepticus (RSE), experience with its use for this indication is limited. OBJECTIVE: - To evaluate the efficacy of continuous intravenous midazolam (cIV-MDZ) for attaining sustained seizure control in patients with RSE. METHODS: The authors reviewed 33 episodes of RSE treated with cIV-MDZ in their neurologic intensive care unit over 6 years. All patients were monitored with continuous EEG (cEEG). MDZ infusion rates were titrated to eliminate clinical and EEG seizure activity; cIV-MDZ was discontinued once patients were seizure-free for 24 hours. Acute treatment failures (seizures 1 to 6 hours after starting cIV-MDZ), breakthrough seizures (after 6 hours of therapy), post-treatment seizures (within 48 hours of discontinuing therapy), and ultimate treatment failure (frequent seizures that led to treatment with pentobarbital or propofol) were identified. RESULTS: All patients were in nonconvulsive SE at the time cIV-MDZ was started; the mean duration of SE before treatment was 3.9 days (range 0 to 17 days). In addition to benzodiazepines, 94% of patients had received at least two antiepileptic drugs (AED) before starting cIV-MDZ. The mean loading dose was 0.19 mg/kg, the mean maximal infusion rate was 0.22 mg/kg/h, and the mean duration of cIV-MDZ therapy was 4.2 days (range 1 to 14 days). Acute treatment failure occurred in 18% (6/33) of episodes, breakthrough seizures in 56% (18/32), post-treatment seizures in 68% (19/28), and ultimate treatment failure in 18% (6/33). Breakthrough seizures were clinically subtle or purely electrographic in 89% (16/18) of cases and were associated with an increased risk of developing post-treatment seizures (p = 0.01). CONCLUSIONS: Although most patients with RSE initially responded to cIV-MDZ, over half developed subsequent breakthrough seizures, which were predictive of post-treatment seizures and were often detectable only with cEEG. Titrating cIV-MDZ to burst suppression, more aggressive treatment with concurrent AED, or a longer period of initial treatment may reduce the high proportion of patients with RSE who relapse after cIV-MDZ is discontinued.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
Treiman, D. M., Meyers, P. D., Walton, N. Y., Collins, J. F., Colling, C., Rowan, A. J., Handforth, A., Faught, E., Calabrese, V. P., Uthman, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391202 · Cited by 1,325
Treatment of refractory generalized status epilepticus with continuous infusion of midazolam
Parent, J. M., & Lowenstein, D. H. (1994) · Neurology · doi:10.1212/wnl.44.10.1837 · Cited by 116
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Self-citationRefractory Status Epilepticus: Frequency, Risk Factors, and Impact on Outcome
Mayer, S. A., Claassen, J., Lokin, J., Mendelsohn, F., Dennis, L. J., & Fitzsimmons, B.-F. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.205 · Cited by 658
Self-citationConsensus Statement on Continuous EEG in Critically Ill Adults and Children, Part I: Indications
Herman, S. T., Abend, N. S., Bleck, T. P., Chapman, K. E., Drislane, F. W., Emerson, R. G., Gerard, E. E., Hahn, C. D., Husain, A. M., Kaplan, P. W., et al. (2015) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000166 · Cited by 654
Self-citationAnesthetic drugs in status epilepticus: Risk or rescue?: A 6-year cohort study
Sutter, R., Marsch, S., Fuhr, P., Kaplan, P. W., & Rüegg, S. (2014) · Neurology · doi:10.1212/wnl.0000000000000009 · Cited by 307
Claassen, J., Hirsch, L. J., Frontera, J. A., Fernandez, A., Schmidt, M., Kapinos, G., Wittman, J., Connolly, E. S., Emerson, R. G., & Mayer, S. A. (2006) · Neurocritical Care · doi:10.1385/ncc:4:2:103 · Cited by 269
Self-citation
Metadata
- Authors
- Claassen, J., Hirsch, L. J., Emerson, R. G., Bates, J. E., Thompson, T. B., & Mayer, S. A.
- Venue
- Neurology
- Published
- 2001-09-25
- Volume
- 57
- Issue
- 6
- Pages
- 1036-1042
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2063689497
- Cited by
- 220
- References
- 2
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. https://app.cochat.ai/papers/10.1212/wnl.57.6.1036
- The paper
- Claassen, J., Hirsch, L. J., Emerson, R. G., Bates, J. E., Thompson, T. B., & Mayer, S. A. (2001). Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. https://doi.org/10.1212/wnl.57.6.1036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.